首页> 外文期刊>Experimental & molecular medicine. >Pigment epithelium-derived factor from ARPE19 promotes proliferation and inhibits apoptosis of human umbilical mesenchymal stem cells in serum-free medium
【24h】

Pigment epithelium-derived factor from ARPE19 promotes proliferation and inhibits apoptosis of human umbilical mesenchymal stem cells in serum-free medium

机译:来自ARPE19的色素上皮衍生因子在无血清培养基中促进人脐带间充质干细胞增殖并抑制其凋亡

获取原文
       

摘要

Clinical expansion of mesenchymal stem cells (MSCs) is hampered by the lack of knowledge regarding how to prevent MSC apoptosis and promote their proliferation in serum-free medium. Our in vitro studies demonstrated that human umbilical cord MSCs (HUCMSCs) underwent apoptosis in the serum-free medium. When HUCMSCs were co-cultured with retinal pigment epithelial cells (ARPE19), however, HUCMSCs exhibited normal growth and morphology in serum-free medium. Their colony formation was promoted by the conditioned medium (CM) of ARPE19 cells on Matrigel. Proteomics analysis showed that pigment epithelium-derived factor (PEDF) was one of the most abundant extracellular proteins in the ARPE19 CM, whereas enzyme-linked immunosorbent assay confirmed that large amounts of PEDF was secreted from ARPE19 cells. Adding anti-PEDF-blocking antibodies to the co-culture of HUCMSCs with ARPE19 cells increased apoptosis of HUCMSCs. Conversely, treatment with PEDF significantly reduced apoptosis and increased proliferation of HUCMSCs in serum-free medium. PEDF was further demonstrated to exert this anti-apoptotic effect by inhibiting P53 expression to suppress caspase activation. In vivo studies demonstrated that co-injection of HUCMSCs with ARPE19 cells in immunocompromised NOD-SCID mice also increased survival and decreased apoptosis of HUCMSCs. PEDF also showed no negative effect on the mesoderm differentiation capability of HUCMSCs. In conclusion, this study is the first to demonstrate that PEDF promotes HUCMSC proliferation and protects them from apoptosis by reducing p53 expression in the serum-free medium. This study provides crucial information for clinical-scale expansion of HUCMSCs.
机译:缺乏有关如何预防MSC凋亡并促进其在无血清培养基中增殖的知识,阻碍了间充质干细胞(MSCs)的临床扩展。我们的体外研究表明,人脐带MSC(HUCMSC)在无血清培养基中发生凋亡。但是,当HUCMSC与视网膜色素上皮细胞(ARPE19)共培养时,HUCMSC在无血清培养基中表现出正常的生长和形态。通过在基质胶上的ARPE19细胞的条件培养基(CM)促进它们的集落形成。蛋白质组学分析表明,色素上皮衍生因子(PEDF)是ARPE19 CM中最丰富的细胞外蛋白之一,而酶联免疫吸附测定证实ARPE19细胞分泌了大量PEDF。在HUCMSC与ARPE19细胞的共培养物中添加抗PEDF阻断抗体会增加HUCMSC的凋亡。相反,用PEDF处理可显着减少无血清培养基中HUCMSC的凋亡并增加其增殖。进一步证明了PEDF可以通过抑制P53表达来抑制caspase激活来发挥这种抗凋亡作用。体内研究表明,在免疫功能受损的NOD-SCID小鼠中共同注射HUCMSC与ARPE19细胞也可以提高HUCMSC的存活率并减少其凋亡。 PEDF对HUCMSCs的中胚层分化能力也没有显示负面影响。总之,这项研究是第一个证明PEDF通过减少无血清培养基中p53的表达来促进HUCMSC增殖并保护它们免受凋亡的作用。该研究为HUCMSCs的临床规模扩展提供了关键信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号